Rare cancer responds unusually well to new treatment
Sunday, September 27, 2015 - 16:30
in Health & Medicine
Results from a multi-center randomized international trial of an innovative treatment show a marked improvement in the length of time patients with mid-gut neuroendocrine tumors live without the disease getting worse.